Kaitlin Soye, PhD
- she / her / hers
- Bio
- Awards & Recognition
- Professional Involvement
- Selected Speaking Engagements
- Selected Publications
- Insights
- Education
Kaitlin is an intellectual property lawyer who enjoys collaborating with clients to develop effective IP strategies. As a trained scientist with a PhD in experimental medicine, she is adept at fusing legal and scientific principles to devise creative solutions to complex problems.
Kaitlin is a member of the firm’s Intellectual Property and Litigation & Dispute Resolution Groups. She represents a broad range of clients, including pharmaceutical, life sciences, technology and telecommunication companies, specifically with regulatory and IP litigation needs.
Kaitlin has extensive Federal Court experience and is efficient at managing the challenges that accompany complex litigation. She leverages her scientific background to represent life sciences and pharmaceutical industry clients in patent and regulatory disputes.
Awards & Recognition
- Recognized in The Best Lawyers in Canada as a "Leading Lawyer to Watch" in the area of Intellectual Property Law (2022, 2023)
Professional Involvement
Memberships
- Member-at-Large, Intellectual Property Law Section, Canadian Bar Association
- Litigation Committee, Intellectual Property Institute of Canada, 2021-Present
- Law Society of Ontario
- The Advocates’ Society
- Member-at-Large, Information Technology and Intellectual Property Law Executive, Ontario Bar Association
- Toronto Intellectual Property Group
- Mentorship Program, First Generation Network
Selected Speaking Engagements
Presenter, “Anatomy of a Patent Trial,” ILCO’s Advanced Litigation Law CLE Program, November 20, 2019
Speaker, “OCI Demystified 2019,” Winsor Law’s OCI Demystified event, July 12, 2019
Selected Publications
Co-author, "Direction From the Court on the Role of Expert Witnesses in Patent Cases," Aird & Berlis Intellectual Property Flash, July 11, 2023.
Author, "Five Tips For Working With Self-Represented Litigants in IP Matters," Ontario Bar Association: Information Technology and Intellectual Property Law, February 25, 2023.
Author, “Digging into the 2022 Federal Budget: Intellectual Property Issues,” Ontario Bar Association: Information Technology and Intellectual Property Law, May 7, 2022
Co-author, “Motions to Inspect Documents on Property,” Intellectual Property Litigation: Forms and Precedents, April 19, 2016
Co-author, “In vitro inhibition of mumps virus by retinoids,” Virology Journal, 2013 Nov 14;10:337, November 14, 2013
Co-author, “Genotype-driven recruitment: a strategy whose time has come?,” BMC Med Genomics 6, 19, May 23, 2013
Co-author, “RIG-I is required for the inhibition of measles virus by retinoids,” PLOS ONE 6(7) July 19, 2011
Co-author, “In vitro and in vivo cleavage of HIV-1 RNA by new SOFA-HDV ribozymes and their potential to inhibit viral replication,” RNA Biol 2011, March 1, 2011
Co-author, “Inhibition of HIV-1 expression and replication by SOFA-HDV ribozymes against Tat and Rev mRNA sequences,” Retrovirology 2009, September 24, 2009
Co-author, “Small interfering RNAs against the TAR RNA binding protein, TRBP, a Dicer cofactor, inhibit human immunodeficiency virus type 1 long terminal repeat expression and viral production,” Virology Journal, March 14, 2007
Insights
Education
- LLB/BCL, McGill University, 2014
- PhD, Experimental Medicine, McGill University, 2011
- Graduate Certificate, Business Administration, Concordia University, 2010
- MSc, Microbiology and Immunology, McGill University, 2007
- B.Sc. (Hons.), Molecular Biology and Genetics, University of Guelph, 2005